Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. (Q44850143)
Jump to navigation
Jump to search
scientific article published on 29 March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. |
scientific article published on 29 March 2004 |
Statements
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial (English)
O Launay
L Roudière
N Boukli
B Dupont
F Prévoteau du Clary
O Patey
F David
O Lortholary
A Devidas
C Piketty
E Rey
R Urbinelli
J M Tréluyer
E Caumes
Viramune-Zyrtec Study Group